Anne Marie Healy

Has grant

Professor (Personal Chair) of Pharmaceutics and Pharmaceutical Technology

Trinity College Dublin
Country flagIreland

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Commercialisation Fund Proof of Concept Award

Open Date: 2023-01-01

Close Date: 2024-01-01

Grant: Open

TCD Panoz Pharmaceutical Innovation PhD Scholarship

Open Date: 2023-01-01

Close Date: 2027-01-01

Grant: Open

EPSRC-SFI Centre for Doctoral Training (CDT) Partnership Programme

Open Date: 2019-01-01

Close Date: 2027-01-01

Grant: Close

SSPC Pharmaceutical Research Centre Phase 2

Open Date: 2019-01-01

Close Date: 2025-01-01

Grant: Close

IRC/APC Ltd. Employment Based PhD Programme

Open Date: 2018-01-01

Close Date: 2022-01-01

Articles (15)

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Several studies have demonstrated the feasibility of in situ co-crystallization in different pharmaceutical processes such as spray drying, hot melt extrusion, and fluidized bed granulation (FBG) to produce co-crystal-in-excipient formulations. However, no previous studies have examined such a one step in situ co-crystallization process for co-crystal formulations where the coformer is a polymer. In the current study, we explored the use of FBG to produce co-crystal granules of dapsone (DAP) and different molecular weight polyethylene glycols (PEGs). Solvent evaporation (SE) was proven to generate DAP-PEGs co-crystals at a particular weight ratio of 55:45 w/w between DAP and PEG, which was subsequently used in FBG, using microcrystalline cellulose and hydroxypropyl methyl cellulose as filler excipient and binder, respectively. FBG could generate co-crystals with higher purity than SE. Granules containing DAP-PEG 400 co-crystal could be prepared without any additional binder. DAP-PEG co-crystal granules produced by FBG demonstrated superior pharmaceutical properties, including flow properties and tableting properties, compared to DAP and DAP-PEG co-crystals prepared by SE. Overall, in situ co-crystallization via FBG can effectively produce API-polymer co-crystals and enhance the pharmaceutical properties.

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (12)

Gavin P Andrews

Professor

The Queen's University Belfast

UNITED KINGDOM
View details

Peter O Connell

Trinity College Dublin

IRELAND
View details

Raquel Fernández-García

Assistant Professor

Universidad Complutense de Madrid

SPAIN
View details

Simon E. Lawrence

University College Cork

IRELAND
View details

Abina Crean

Professor of Pharmaceutics

University College Cork

IRELAND
View details

Steven Ferguson

Dublin City University

IRELAND
View details

Fiona McCartney

University College Dublin

IRELAND
View details

Timothy M. Korter

Syracuse University

UNITED STATES
View details

Dolores Remedios Serrano

Assitant Professor - Profesor Ayudante Doctor

Universidad Complutense de Madrid

SPAIN
View details

Luke M. Geever

Technological University of the Shannon

IRELAND
View details

David Brayden

Professor of Advanced Drug Delivery

Dublin City University

IRELAND
View details

Aikaterini Lalatsa

University Of Strathclyde

UNITED KINGDOM
View details